TABD Companies Urge Governments to Drive Innovation

The TransAtlantic Business DialogueThe TransAtlantic Business Dialogue (TABD) held its Innovation Conference Healthcare under the patronage of German Chancellor Angela Merkel, who has made transatlantic innovation a key tenet of the EU presidency. The conference, which brought together American and European participants, including political leaders and scientific experts, presented four recommendations to improve innovation in healthcare and healthcare delivery.

Speakers at the TABD conference, noting aging demographics and escalating healthcare costs on both sides of the Atlantic, urged the European Union and the U.S. Government to:

  • Recognize healthcare as an infrastructure component that serves as both the means to improve people's health and well-being and a key economic driver;
  • Accelerate the deployment of healthcare innovations by harmonizing standards, streamlining approval processes and protecting intellectual property rights;
  • Foster innovation and redirect financial incentives to focus on prevention, early detection and continuity of care; and
  • Establish an expert panel to develop benchmarking and best practices, working with the European Commission, the U.S. Government and the TABD Innovation Working Group.

Among OECD countries, the healthcare sector will more than triple to $10 trillion by 2020, according to "HealthCast 2020: Creating a Sustainable Future," a report by PricewaterhouseCoopers. The report stated that the healthcare sector is challenged by a confluence of powerful trends that include increasing demands, rising costs, uneven quality and misaligned incentives.

"Our aging populations and rising demand for higher-quality care accentuate the inefficiencies across the healthcare spectrum," said Klaus Kleinfeld, President and CEO of Siemens AG and Co-Chair of the TABD Innovation Working Group. "Consequently, we need to put the patient at the center of an improved healthcare system by developing and deploying innovations in technology and service delivery."

Richard T. Clark, Chairman, President and CEO of Merck & Co., Inc. (USA) and Cochair of the Innovation Working Group called for developing new ways of thinking about healthcare investment and spending. "Advances in medical technology and patient care set the stage to deliver prevention instead of treatment. As we build this capability, we want governments and other financial providers to think of healthcare spending as an investment that should be encouraged – not as a cost to be managed."

Speakers at the event included German Federal Minister of Education and Research Annette Schavan; European Commission Vice President Günter Verheugen; Deputy Secretary of the U.S. Department of Commerce David A. Sampson, Hans Hoogervorst former Minister of Health, Welfare and Sports, The Netherlands; and Newt Gingrich, Founder of the Center for Health Transformation and former Speaker, U.S. House of Representatives.

About the TransAtlantic Business Dialogue Innovation Conference Healthcare
As Co-Chairmen of the TransAtlantic Business Dialogue (TABD) Innovation Working Group Klaus Kleinfeld, CEO Siemens AG, and Richard Clark, Chairman, President and CEO of Merck & Co. Inc. (USA) co-hosted the TABD Innovation Conference Healthcare in Berlin on May 8, 2007. The TABD Innovation Conference was organized by the TABD and sponsored by AstraZeneca, General Electric, Microsoft, Merck Sharp & Dohme (MSD), Pfizer, Philips, PricewaterhouseCoopers and Siemens AG.

About the TransAtlantic Business Dialogue
The TABD brings together the CEOs of more than 30 European and U.S. companies operating in the United States, Europe and globally, with the aim of promoting closer commercial ties between the US and the European Union. The current TABD Chairmen are Martin Broughton, Chairman of British Airways and Charles Prince, Chairman and Chief Executive Officer of Citigroup. Originally launched with the support of the U.S. Department of Commerce and the European Commission in Seville in 1995, it was relaunched in a new format in 2003. The TABD is a unique and effective organization whose primary goal is to help establish a barrier-free transatlantic market with the freest possible exchange of goods, services and capital between the EU and US. The TABD advocates global trade liberalization as a means to greater prosperity for all countries, which in turn will help stimulate innovation, investment, economic growth, and job creation.

For further information, please visit:

Related news articles::

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...